-Yoshiyuki Suzuki Researcher Activity Profile

Research Author Detailed Information 

Yoshiyuki Suzuki Publication Rate By Year

Yoshiyuki Suzuki has published 1 paper(s) in 2006, 20 paper(s) in 2007, 13 paper(s) in 2008, for a total of 34 research publications in total.

Yoshiyuki Y Suzuki Author Information

LAST NAME: suzuki

FIRST NAME: yoshiyuki

INITIALS: Y

AFFILIATION:

Papers

Yoshiyuki Suzuki's Publication Record

1. Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter. Year Published: 2006
Department of Gastroenterology, Toranomon Hospital, Okinaka Memorial Institute for Medical Research, Toranomon 2-2-2, Minato-ku 105-8470, Tokyo, Japan.
2. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Year Published: 2007
Department of Hepatology, Toranomon Hospital and the Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
3. Multiple transmissions of tick-borne encephalitis virus between Japan and Russia. Year Published: 2007
Center for Information Biology and DNA Data Bank of Japan, National Institute of Genetics, Japan. yossuzuk@lab.nig.ac.jp
4. Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
5. Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
6. Inferring natural selection operating on conservative and radical substitution at single amino acid sites. Year Published: 2007
Institute of Molecular Evolutionary Genetics and Department of Biology, The Pennsylvania State University, USA. yis1@psu.edu
7. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
8. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital.
9. Prolonged hepatitis after acute infection with genotype h hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital.
10. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan, and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
11. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jp
12. Prolonged hepatitis after acute infection with genotype H hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo.
13. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
14. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
15. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jp
16. Prolonged hepatitis after acute infection with genotype H hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo.
17. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
18. Evola: Ortholog database of all human genes in H-InvDB with manual curation of phylogenetic trees. Year Published: 2008
Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics Consortium, Tokyo, Japan.
19. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
20. Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis. Year Published: 2008
Graduate School, International University of Health and Welfare, Otawara.
21. Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis. Year Published: 2008
Graduate School, International University of Health and Welfare, Otawara, Japan. suzukiy@iuhw.ac.jp
22. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
23. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
24. Evola: Ortholog database of all human genes in H-InvDB with manual curation of phylogenetic trees. Year Published: 2008
Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics Consortium, Tokyo, Japan.
25. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
26. Evola: Ortholog database of all human genes in H-InvDB with manual curation of phylogenetic trees. Year Published: 2008
Integrated Database Group, Japan Biological Information Research Center, Japan Biological Informatics Consortium, Tokyo, Japan.
27. The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts. Year Published: 2008
Japan Biological Information Research Center, Japan Biological Informatics Consortium, Japan.
28. Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis. Year Published: 2008
Graduate School, International University of Health and Welfare, Otawara, Japan. suzukiy@iuhw.ac.jp
29. Inferring natural selection operating on conservative and radical substitution at single amino acid sites. Year Published: 2007
Institute of Molecular Evolutionary Genetics and Department of Biology, The Pennsylvania State University, USA. yis1@psu.edu
30. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
31. Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis. Year Published: 2008
Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University, 86 Nishi-machi, Yonago 683-8503, Japan.
32. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
33. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. ZXC00701@nifty.ne.jp
34. Efficacy in patients with dose reduction in combination therapy of peginterferon and ribavirin for chronic hepatitis C. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. es9y-ars@asahi-net.or.jp